Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Actinogen's Xanamem misses primary endpoint in pivotal Alzheimer's trial as company turns to older patients
November 19, 2026 - - Latest News -
Independent review backs a fresh look at Paradigm's iPPS outside the US
November 19, 2026 - - Latest News -
Syntara looks for a partner after promising amsulostat data
November 19, 2026 - - Latest News -
Genetic Signatures walks away from Microba merger after funding shortfall
November 19, 2026 - - Latest News -
Immutep goes back to smaller batch efti after review finds glycan differences in trial candidate
November 19, 2026 - - Latest News -
BCAL widens breast cancer research beyond lipids as its science goes through peer review
November 17, 2026 - -
AusBiotech opens call for sessions for Brisbane's 2027 'Biggest Week in Biotech'
November 17, 2026 - - AusBiotech